Bone marrow-derived stem cells for treatment of severe chronic ischemic heart disease

The aim of this study is to assess the efficacy of surgical revascularization and myocardial transplantion of autologous bone marrow-derived stem cells (BM-SCs), for the treatment of severe chronic ischemic heart disease, as compared to surgical revascularization alone.